Drug
Who makes alpelisib?
2 companies list alpelisib as a human prescription drug, including under the names PIQRAY, VIJOICE. Forms: granule; kit; tablet. Routes: oral.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing alpelisib
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Novartis Pharmaceuticals CorporationSwitzerland | granule; kit; tablet | NDANDA212526, NDA215039, NDA218466 | 7 | 20 |
| Novartis Pharma Stein AG | tablet | DRUG FOR FURTHER PROCESSING | 6 | 0 |
Bulk ingredient listings
- Novartis Pharmaceuticals CorporationSwitzerland · 1 NDC
- SciAnda (Changshu) Pharmaceuticals, Ltd.China · 1 NDC
Orange Book patents
4 unexpired patents list alpelisib as the active ingredient, expiring between Sept 2029 and Feb 2037. Application holder: NOVARTIS PHARMACEUTICALS CORP.
Enquiry
Common questions
- Who makes alpelisib?
- 2 companies list alpelisib as a human prescription drug in the openFDA NDC Directory, led by Novartis Pharmaceuticals Corporation, Novartis Pharma Stein AG. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Who supplies alpelisib active ingredient?
- 2 companies list alpelisib as a bulk ingredient, including Novartis Pharmaceuticals Corporation, SciAnda (Changshu) Pharmaceuticals, Ltd..